Welcome to the website of the ACTION trial: a multicenter, randomised, open, blinded endpoint (PROBE) clinical trial in the Netherlands investigating the effect of anakinra on secondary brain injury after spontaneous intracerebral haemorrhage. This trial is funded by the Dutch Heart Foundation.
This website is ment as a source of information for researchers. The menu in the upperpart of this page helps you to navigate through this website.